Ero Copper (ERO) stock analysis: undervalued copper-gold miner with low costs, growth, FY25 guidance, and takeover potential.

The latest update on McEwen stock reflects a slightly higher fair value estimate of US$22.60 per share, up from US$22.20, and ...

APLD's fiscal Q2 revenues surge 250% on HPC tenant fit-outs at Polaris Forge 1, but higher costs pushed earnings below ...

Cytokinetics should hear back from the FDA next September about its marketing application for aficamten, which is vying to become the first rival to Bristol-Myers Squibb's fast-growing Camzyos for ...

Discover essential tips to excel in Series 7 options and stock strategy questions. Enhance your understanding and boost your ...